Amicogen (China) Biopharm Co., Ltd.: Leading Biotechnology and Pharmaceutical Innovation
Amicogen (China) Biopharm Co., Ltd., headquartered in Jining, China, is a global leader in the development and manufacturing of active pharmaceutical ingredients (APIs), pharmaceutical intermediates, industrial enzymes, and resins. As part of the Amicogen Group, the company is dedicated to biotechnology-driven innovation, sustainable production, and high-quality pharmaceutical solutions.
Core Business and Specialization
Amicogen (China) Biopharm specializes in biopharmaceutical manufacturing and enzyme-based bioprocesses, focusing on:
- Active Pharmaceutical Ingredients (APIs) – High-purity beta-lactam antibiotics and specialty APIs
- Pharmaceutical Intermediates – Key intermediates for cephalosporin and penicillin synthesis
- Enzyme-Based Bioprocessing – Advanced enzymatic catalysis technology for antibiotic production
- Specialty Resins – High-efficiency ion exchange and adsorption resins for pharmaceutical purification
With a strong research-driven approach, Amicogen (China) Biopharm ensures compliance with global pharmaceutical standards while optimizing efficiency and environmental sustainability.
Product and Service Offerings
1. Active Pharmaceutical Ingredients (APIs)
Amicogen produces high-quality APIs used in veterinary and human medicine, including:
- Ceftiofur Hydrochloride – A broad-spectrum cephalosporin antibiotic
- Cefaclor – A widely used second-generation cephalosporin
2. Pharmaceutical Intermediates
Key building blocks for antibiotic synthesis, ensuring high yield and purity:
- 6-APA (6-Aminopenicillanic Acid) – Essential for penicillin manufacturing
- 7-ACA (7-Aminocephalosporanic Acid) – A precursor for cephalosporin antibiotics
3. Industrial Enzymes for Biopharma Applications
Amicogen utilizes enzyme-based bioprocessing technology to enhance API production efficiency:
- Cephalosporin C Acylase – Enzyme for 7-ACA production with high specificity
- D-7-ACA Esterase – Used in semi-synthetic cephalosporin synthesis
4. Resins for Pharmaceutical Purification
High-performance resins for biopharmaceutical and chemical purification:
- Ion Exchange Resins – Optimized for API separation and purification
- Macroporous Adsorption Resins – Used in drug formulation and purification
Market Position and Global Reach
With a strong presence across Asia, Europe, and North America, Amicogen (China) Biopharm is a trusted supplier of pharmaceutical intermediates and enzyme-based bioprocessing solutions.
- Exports to over 50 countries worldwide
- Annual production capacity exceeding 500 metric tons of APIs
- State-of-the-art biomanufacturing facility covering 100,000 square meters
Shipment Data and Export Markets
Amicogen (China) Biopharm supplies leading pharmaceutical and veterinary drug manufacturers, exporting to:
- Europe (Germany, Spain, France) – Growing demand for high-purity antibiotic APIs
- United States & Canada – Expansion in biopharmaceutical enzyme solutions
- Asia (Japan, South Korea, India) – Strong presence in antibiotic intermediate markets
Certifications and Compliance
The company adheres to stringent international quality and safety standards, including:
- GMP (Good Manufacturing Practice) Certified – Ensuring pharmaceutical-grade production
- ISO 9001:2015 Certification – Quality management system compliance
- DMF (Drug Master File) Registration – Approved by regulatory authorities in the US, EU, and China
Customer Testimonials and Industry Recognition
Amicogen (China) Biopharm has received global recognition for its high-quality pharmaceutical and enzyme products:
- “The enzyme-based antibiotic synthesis technology from Amicogen has improved our cephalosporin production efficiency by 30%.” – Pharmaceutical Manufacturer, Germany
- “Their high-purity Ceftiofur API has helped us achieve better stability and effectiveness in veterinary formulations.” – Veterinary Drug Producer, South Korea
Recognized as a leader in enzyme-based pharmaceutical processing, the company has received:
- Top 10 Pharmaceutical Biotechnology Companies in Asia (2023)
- Best API Manufacturer – China (2022)
Major Achievements and Future Growth
- Investment in AI-driven bioprocess optimization for API production
- Expansion of enzyme technology applications in green pharmaceutical manufacturing
- Development of next-generation antibiotic intermediates for higher efficiency and sustainability
With a commitment to innovation, regulatory excellence, and environmental sustainability, Amicogen (China) Biopharm continues to lead the biopharmaceutical manufacturing industry worldwide.
